v3.26.1
NATURE OF BUSINESS & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Deferred Revenue Activity The following table represents the deferred revenue activity for the three months ended June 30, 2026, and 2025:
In Thousands20262025
Balance as of March 31,$449 $863 
Unearned revenue from cash received during the period180 112 
Revenue recognized that was included in the balance at the beginning of the period(2)(57)
Balance as of June 30,$627 $918 


The following table represents the deferred revenue activity for the six months ended June 30, 2026, and 2025:

In Thousands20262025
Balance as of December 31,$536 $932 
Unearned revenue from cash received during the period624 914 
Revenue recognized that was included in the balance at the beginning of the period(533)(928)
Balance as of June 30,$627 $918 
Schedule of Computation of Basic and Diluted Net Loss Per Share of Class A Common Stock The following table shows the computation of basic and diluted net loss per share of Class A Common Stock for the three and six months ended June 30, 2026, and 2025:
Three Months Ended June 30,Six Months Ended June 30,
In Thousands, Except Share and Per Share Amounts2026202520262025
Numerator:
Net loss attributable to Cibus, Inc. stockholders$(22,145)$(25,372)$(43,367)$(72,258)
Denominator:
Weighted average shares of Class A common stock outstanding76,355,93638,148,01470,611,00634,879,069
Effect of pre-funded warrants400,0003,470,879400,0003,474,862
Weighted average shares of Class A common stock outstanding – basic and diluted76,755,93641,618,89371,011,00638,353,931
Basic and diluted net loss per share of Class A common stock$(0.29)$(0.61)$(0.61)$(1.88)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their antidilutive effect:
As of June 30,
20262025
Stock options outstanding3,805,0721,309,968
Unvested restricted stock units2,829,8171,108,895
Unvested restricted stock awards40,057153,490
Common warrants10,496,52310,496,523
Total17,171,46913,068,876
Schedule of Segment Financial Information Used by CODM to Assess Segment Performance and Make Decisions
Segment financial information, including significant segment expenses, which are regularly provided to the CODM and included in net loss was as follows:

Three Months Ended June 30,Six Months Ended June 30,
In Thousands2026202520262025
Revenue$994 $933 $2,675 $1,967 
Less:
Personnel expenses5,2246,78711,01213,548
Professional fees2,0002,7083,3248,131
Stock-based compensation1,4841,9783,0554,477
Goodwill impairment———20,950
Other segment expenses (1)
5,2117,40610,32914,378
Total operating expenses13,91918,87927,72061,484
Loss from operations(12,925)(17,946)(25,045)(59,517)
Royalty liability interest expense - related parties(9,475)(8,668)(18,596)(17,045)
Other interest income, net111106139225
Non-operating income (expense), net150(23)148416
Income tax expense(6)(27)(13)(29)
Total segment loss$(22,145)$(26,558)$(43,367)$(75,950)

_______________________________________
(1) Other segment expenses are primarily comprised of facilities and asset related expenses such as rent, asset depreciation and amortization, utilities, property taxes, and repairs and maintenance and also include insurance, dues and subscriptions, licenses, lab supplies, product development, and travel.